EASA SIB 2013-21: WITHDRAWN - SEE Annex to EASA ED Decision 2014/029/R

What to do

Operators should conduct hazard identification and risk assessments before expanding the use of non-transmitting PEDs and update their operations manuals accordingly. They must provide clear passenger briefings on PED policies, ensure crew training on PED procedures, and report any PED-related events to competent authorities. Additionally, operators are encouraged to evaluate their aircraft for PED tolerance and comply with telecommunication regulations before permitting transmitting PED use.

Summary

The EASA Safety Information Bulletin 2013-21 titled 'WITHDRAWN - SEE Annex to EASA ED Decision 2014/029/R' provides guidance on the use of Portable Electronic Devices (PEDs) during commercial air transport operations. It addresses the regulatory framework under Regulation (EU) No. 965/2012, focusing on the safe use of non-transmitting and transmitting PEDs on board aircraft. The bulletin is applicable to commercial air transport operators and National Aviation Authorities overseeing these operations.

What changed

This bulletin updates the Acceptable Means of Compliance and Guidance Material related to PED use, allowing operators to permit the use of non-transmitting PEDs during all phases of flight. It introduces recommendations for hazard identification and risk management before expanding PED use and provides initial guidance on transmitting PEDs (T-PEDs). The document also revises the phases of flight definitions relevant to PED restrictions and encourages operators to assess aircraft PED tolerance.

Why it matters

The bulletin is important for aviation professionals as it clarifies the regulatory expectations and safety considerations for PED use on commercial flights, impacting passenger management and operational procedures. It helps operators ensure compliance with EU regulations while managing risks associated with PED interference. The guidance supports harmonization of PED policies across operators, reducing passenger confusion and enhancing safety during critical flight phases.